glp 1 acronym View of GLP-1 receptor agonists in type 2 diabetes - NICE guidelines versus clinical practice The Surprising Truth About Nutrition

In agreement with expectations, the first outcome trial of a GLP-1RA, the ELIXA trial of the short-acting lixisenatide, an exendin-4 derivative with properties almost identical to those of exendin-4 or exenatide (stable, full agonists of the GLP-1 receptor), showed no increased cardiovascular risk in a patient group with severely increased CVD risk

For patients managing Hashimotos, GLP-1 therapy can offer advantages beyond the scale

Blood tests to check HbA1c, fasting glucose, or immune function may be appropriate

The goal is simple: light but nutrient-packed dishes that deliver fiber, protein, and lasting energy, without weighing you down or triggering nausea

Alhadeff AL, Mergler BD, Zimmer DJ, Turner CA, Reiner DJ, Schmidt HD, Grill HJ, and Hayes MR